PharmaCyte Biotech, Inc. (PMCB)
NASDAQ·Healthcare·Biotechnology
$0.77
+0.96%
Mkt Cap $4.76M
No analyst coverage available
We don't have analyst ratings or price target data for PharmaCyte Biotech, Inc. yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.